Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 1369-1372, October 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weiss, L.
Right arrow Articles by Hakala, M. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiss, L.
Right arrow Articles by Hakala, M. T.

The Anionic Nature of Sarcoma 180 Cell Surfaces, and Sensitivity to 4,4'-Diacetyldiphenylurea-bis(guanylhydrazone)1

L. Weiss and M. T. Hakala

Departments of Experimental Pathology and Experimental Therapeutics, Roswell Park Memorial Institute, Buffalo, New York 14203

The electrokinetic surfaces of sublines of murine Sarcoma 180 cells, which were resistant or sensitive to 4,4'-diacetyldiphenylurea-bis(guanylhydrazone)-dimethane sulfonate (DDUG) were examined. No significant differences were detected between either the net negative surface charges of the two cell lines or the respective contributions to cell surface negativity of bound, anionic groups susceptible to neuraminidase or RNase. However, the alteration of the response of the two sublines to growth inhibition by DDUG after RNase and neuraminidase treatments was significantly different. Treatments with these enzymes increased the resistance of the sensitive cells to DDUG 3- and 2-fold, respectively, while the response of the Sarcoma 180 DDUG-resistant subline to the drug was unaltered by enzyme treatment. The findings are discussed with regard to the structure and charge characteristics of the DDUG molecule in relation to the possible differences in the spatial arrangements of the anionic sites at the surfaces of the sensitive and resistant cells.

1 Supported in part by USPHS Grants CA-04175 and CA-11047 from the National Cancer Institute and by June Lambert Memorial Grant P403-D from the American Cancer Society, Inc.

Received 3/ 1/71. Accepted 5/17/71.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.